Optiver Holding B.V. Cidara Therapeutics, Inc. Transaction History

Optiver Holding B.V.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 16, 2022	SELL	$0.67 - $1.39 $3,410 - $7,075	-5,090 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$1.87 - $2.7 $9,518 - $13,743	5,090 New	5,090 $10,000

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $1.63B
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of Optiver Holding B.V., based on Form 13F filings with the SEC.

Stay updated on Optiver Holding B.V. with notifications on news.